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Abstract
Background: The accumulation of MWCNTs in the lung environment leads to inflammation and the development
of disease similar to pulmonary fibrosis in rodents. Adverse Outcome Pathways (AOPs) are a framework for defining
and organizing the key events that comprise the biological changes leading to undesirable events. A putative AOP
has been developed describing MWCNT-induced pulmonary fibrosis; inflammation and the subsequent healing
response induced by inflammatory mechanisms have been implicated in disease progression.
The objective of the present study was to address a key data gap in this AOP: empirical data supporting the essentiality
of pulmonary inflammation as a key event prior to fibrosis. Specifically, Interleukin-1 Receptor1 (IL-1R1) and Signal
Transducer and Activator of Transcription 6 (STAT6) knock-out (KO) mice were employed to target inflammation and
the subsequent healing response using MWCNTs as a model pro-fibrotic stressor to determine whether this altered the
development of fibrosis.
Results: Wild type (WT) C57BL/6, IL-1R1 (KO) or STAT6 KO mice were exposed to a high dose of Mitsui-7 MWCNT by
intratracheal administration. Inflammation was assessed 24 h and 28 days post MWCNT administration, and fibrotic lesion
development was assessed 28 days post MWCNT administration. MWCNT-induced acute inflammation was suppressed in
IL-1R1 KO mice at the 24 h time point relative to WT mice, but this suppression was not observed 28 days post exposure,
and IL-1R1 KO did not alter fibrotic disease development. In contrast, STAT6 KO mice exhibited suppressed acute
inflammation and attenuated fibrotic disease in response to MWCNT administration compared to STAT6 WT mice.
Whole genome analysis of all post-exposure time points identified a subset of differentially expressed genes associated
with fibrosis in both KO mice compared to WT mice.
Conclusion: The findings support the essentiality of STAT6-mediated signaling in the development of MWCNT-
induced fibrotic disease. The IL-1R1 KO results also highlight the nature of the inflammatory response associated with
MWCNT exposure, and indicate a system with multiple redundancies. These data add to the evidence supporting an
existing AOP, and will be useful in designing screening strategies that could be used by regulatory agencies to
distinguish between MWCNTs of varying toxicity.
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Background
Carbon nanotubes are among the widely produced
nanomaterials (NMs) globally [1]. Multi-walled carbon
nanotubes (MWCNTs) are the most used variants of this
NM class with a growing number of commercial and
industrial applications [2]. The diverse applications of
MWCNTs are attributed to their unique physical-
chemical properties. MWCNTs possess a fiber-like
structure with a diameter of up to 100 nm and lengths
up to 28,000,000 times their diameter [2], because of
which they exhibit exceptional benefits such as high
mechanical strength, stiffness, and superior thermal and
electric conductivity properties. Moreover, MWCNTs
are polymers of carbon and therefore are amenable for
manipulation of their surface structure. Chemical modi-
fications of MWCNTs can aid in better solubility and
dispersion of the material for various applications. The
very unique and commercially attractive properties also
render them toxic, which is a major issue [3]. The high-
aspect ratio of MWCNTs is comparable to other high
aspect ratio substances such as asbestos, raising further
concerns about their use in various applications [4, 5].
Complicating the situation is the fact that there are
many variants of MWCNTs exhibiting distinct proper-
ties that are suggested to uniquely influence the toxico-
logical outcomes induced by these materials. Thus, there
is a pressing need to characterize the toxicity induced by
these materials and the underlying mechanisms associ-
ated with this toxicity. More urgently, strategies and
tools to rapidly screen toxicity of different types of
MWCNTs and predictive markers of exposure and ef-
fects of MWCNTs are needed.
Several studies have shown that when inhaled,
MWCNTs persist in lungs and induce injury leading to
interstitial and sub-pleural lung fibrosis and granulomas
in rodents. Recent literature suggests that the hallmarks
of MWCNT-induced fibrotic response involve an acute
inflammatory response that is predominantly neutro-
philic in nature, chronicity of inflammation, and ultim-
ately clinical manifestation of fibrotic lesions [6].
However, the essentiality of acute lung inflammation in
lung fibrosis induced by MWCNTs is unclear. Lung fi-
brosis is induced following repeated exposure to certain
types of bacteria or viruses as well as following repeated
exposure to toxic chemical substances. Studies involving
targeted inhibition of specific inflammatory mediators
have demonstrated that inflammatory processes play a
role in the underlying mechanisms of fibrosis induced by
these pro-fibrotic stimulants [7, 8]. For example, target-
ing inflammatory mediators such as IL-17A reduced the
number of fibrotic lesions in mice exposed to the lung-
damaging peptide bleomycin or fibrosis-inducing
bacteria [9, 10]. Similarly, blocking the classical mediator
of inflammation, Tumor necrosis factor (TNF)-α, resulted
in decreased fibro-proliferative disease in the lungs of
mice exposed to asbestos [11], and targeting reactive
oxygen species (ROS) synthesis accompanying an inflam-
matory response resulted in decreased incidences of
asbestos-induced fibrotic lesions [12]. The inflammatory
response is a crucial initiator of secretion of growth factors
and activation of T helper (Th) 2 type cells that are known
to drive the healing response, uncontrolled activation of
which is implicated in the development of fibrosis [9, 10].
Relatively few inflammatory mediators and genes associ-
ated with the healing response have been specifically
studied to determine their role in response to MWCNT-
exposure and pathogenesis. Such data would provide
crucial insight into the key events that lead to MWCNT-
induced disease and help identify sensitive markers of
exposure and adverse effects of MWCNTs.
Using MWCNT as a prototype stressor, we recently
published a putative Adverse Outcome Pathway (AOP)
for lung fibrosis, and identified a Molecular Initiating
Event (MIE) and Key Events (KEs) potentially involved
in the pathology (Fig. 1) [13]. In brief, the MIE involves
cellular sensing of the MWCNTs in the lungs and the
release of danger signals, leading to activation of KE1 -
induction of inflammatory cytokines/chemokines/growth
factors leading to activation of KE2. This is also associ-
ated with infiltration of inflammatory cells into the lung
tissue and is characterized as acute inflammation. KE2
involves retention of MWCNTs, which is associated with
the persistence of inflammatory signals, synthesis of
reactive oxygen species and lung injury, all acting in a
positive feedback loop leading to KE3. KE3 marks
deregulated wound healing process, which is measured
as activation of Th2 type cells and M2 type macro-
phages, and secretion of anti-inflammatory mediators
and growth factors that play an important role in the
progression of lung fibrosis. KE4 and KE5 involve activa-
tion of fibroblast/myofibroblast proliferation and uncon-
trolled ECM deposition leading to fibrotic lesions in the
lungs. In essence, this AOP hypothesized that acute and
subsequent chronic inflammatory conditions play a role
in MWCNT-induced lung fibrosis. In the present study,
we used knock out models of an inflammatory pathway
and the wound healing response to specifically inhibit
inflammation or the subsequent healing response as de-
fined in the AOP to investigate their essentiality to the
overall pathogenesis of lung fibrosis induced by
MWCNTs. Specifically knocking out or enhancing KEs
to demonstrate expected impacts on downstream KEs
and the AO in the expected direction is one of the main
elements of weight of evidence (criteria: essentiality)
assessment in support of an AOP [14, 15]. In this study,
we used knock-out mice to specifically investigate the
essentiality of Interleukin (IL)-1 signaling pathway to in-
hibit acute inflammatory response (KE1) and Signal
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Transducer and Activator of Transcription 6 (STAT6)
mediated signaling (KE3).
The IL-1 signaling pathway is a key coordinator of in-
flammation induced by exposure to various inhaled toxi-
cants [16, 17]. IL-1 was one of the first cytokines to have
been characterized, and its signaling is accomplished
through the binding of the IL-1 receptor (IL-1R1) to one
of two ligands, IL-1α or IL-1β [18]. IL-1 signaling has
been implicated in the development of pulmonary fibro-
sis; overexpression of IL-1β in the lungs of mice results
in the development of fibrotic lesions [19]. This is
further supported by the observations that disruption of
IL-1 signaling results in less fibrosis in IL-1R1 and
MyD88 deficient mice following treatment with bleo-
mycin [20]. More recently, it was shown that MWCNT-
induced lung inflammation is mediated by IL-1 signaling
[21], but a complete characterization of how the
biological responses to MWCNTs are impacted in the
absence of IL-1 signaling and its repercussions on
fibrotic pathology has not been assessed. The transcrip-
tion factor STAT6 is a crucial mediator of Th2 responses
[22, 23]. Experimental models of fibrosis have also found
less disease in STAT6 deficient mice [24, 25]. STAT6
phosphorylation has been measured after MWCNT ex-
posure and it has been proposed to be involved in the
development of MWCNT-induced lung pathology [26],
yet STAT6 has not been directly targeted in a model of
MWCNT exposure.
In the current study we investigated the essentiality of
IL-1 and STAT6 signaling-mediated lung inflammation
in MWCNT-induced lung fibrosis. We exposed IL-1R1
deficient mice or STAT6 deficient mice to Mitsui XNRi-7
(Mitsui-7), a MWCNT variant known to induce lung
fibrosis in experimental rodents. Detailed histopathology
and global gene expression analysis was performed to
characterize the lung responses 1 and 28 day post-
intratracheal instillation of 162 μg/mouse dose of Mitsui-7
and to assess impacts of the KO on downstream KE and
the AO, for pulmonary fibrosis.
Methods
MWCNT characteristics
This study utilized Mitsui XNRi-7 (lot 05072001 K28,
Hodoga Chemical Industry (formerly known as Mitsui)),
which has been classified as a possible human carcinogen
(Group 2B) [27]. Physical-chemical characteristics of
Mitsui-7 have been published previously [28]. In brief,
Mitsui-7 are described as rod-like fibers with an average
length of 3.86 μm and diameter of 49 ± 13.4 nm [28]. Colli-
sion type Inductively Coupled Plasma Mass Spectrometry,
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Fig. 1 Adverse Outcome Pathway (AOP) for the development of MWCNT-induced lung fibrosis. Graphical depiction of the key events that describe
the progression from inhalation exposure to MWCNTs to the development of pulmonary fibrosis. The figure highlights the molecular initiating event
(MIE), key events (KE), associative events (AE), and the adverse outcome (AO)
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Combustion Ion Chromatography and trace metal analysis
detected some impurities, which included Fe: 0.3%, Na:
0.4%, S: ca. 470 ppm and Cl: ca. 20 ppm. This batch of
Mitsui-7 has been assessed for endotoxin contamination
previously and is shown to contain negligible levels of
endotoxin [29].
MWCNT preparation and administration
Mitsui-7 suspensions were prepared fresh for each ex-
periment. A total of 8.9 mg of Mitsui-7 was suspended
in NanoPure water containing 2% serum collected from
C57BL/6 mice to a total stock suspension of 3.24 mg/ml.
Suspensions were prepared by sonicating the particle
preparations using a Branson Sonifier S-450D (Branson
Ultrasonics Corp., Danbury, CT) equipped with a dis-
ruptor horn (Model number: 101–147-037). Total sonic-
ation time was 21 min at 40 W. The samples were
continuously cooled on ice during the sonication
procedure. 50 μl of the suspension was used for the
162 μg/mouse dose. Vehicle controls were prepared as
described above with only NanoPure water and 2%
serum. The 162 μg/mouse dose was selected based on
the results of our previous studies, at which Mitsui-7 is
shown to induce fibrosis in C57BL/6 mice [30]. Mitsui-7
was specifically chosen because of the established observa-
tion of lung pathology induced by this MWCNT [30, 31].
Animal care and exposure
Female wild type C57BL/6 mice (WT) and C57BL/6
mice deficient in IL-1R1 (IL1-R1 KO) or STAT6 (STAT6
KO), age 5–8 weeks old, were purchased from Jackson
Laboratory (Bar Harbor, ME). Mice were acclimatized
for a week. Mice were housed under specific pathogen-
free conditions on a 12-h light-dark cycle with food and
water provided ad libitum. All animal procedures were
approved and followed the care and handling guidelines
for laboratory animals established by the Health Canada
Animal Care Committee.
Animal exposure and tissue collection
Each treatment group consisted of 10 animals; 5 animals
were used to collect tissues for bronchoalveolar lavage
fluid (BAL) and RNA/protein extraction, and 5 animals
were used to collect tissues for histology. Mice were
anesthetized by inhalation of 5% isoflurane (Isoflo,
Esteve Farma, Carnaxide, Portugal) in 100% oxygen.
Mice in the experimental group received a single intra-
tracheal instillation of 162 μg of Mitsui-7 in a 50 μl
freshly prepared suspension, as described above,
followed by 150 μl of air with a 250 μl SGE glass syringe
(250F–LT-GT, MicroLab, Aarhus, Denmark). Control
mice received 50 μl of vehicle (2% serum in nanopure
water) only followed by 150 μl of air. Mice were kept
under observation until they recovered from anesthesia.
Mice were sacrificed 1 and days 28 post-exposure. BAL
and lung tissue were collected. BAL was performed by
lavaging the lungs twice with 1 ml saline using a 2 ml
syringe. Each lavage consisted of 3 up and down
movements performed slowly (5–10 s each) and the fluid
was immediately placed on ice until the analysis. Post-
lavage, the right and left lobes of lung were cut in pieces,
snap frozen in liquid nitrogen, and stored at −80 °C. The
lung tissues from other 5 animals were fixed for
histology as described below under the histology section.
BAL cell count
The combined lavage volume recovered was estimated
and BAL fluid and BAL cells were separated by centrifu-
gation at 4 °C and 400 g for 10 min. The total cell
number (TCN) was determined per volume using a
Moxi Z OS 4.0 cell counter (ORFLO Technologies,
Hailey, ID). Cytospins were prepared and stained with
Hema 3 (Bio- chemical Sciences, Swedesboro, NJ). Five
hundred cells were counted per cytospin for determin-
ation of percent mononuclear cells and percent neutro-
phils. Differential cell counts were calculated using this
percentage and the total cell number.
BAL inflammatory cytokine measurement
IL-1α, CXCL1, IL-6, IL-12p40, CCL2, IL-5, and granulo-
cyte colony stimulating factor (G-CSF) were measured
in BAL by Mouse Cytokine Bio-Plex Pro (Bio-Rad,
Hercules, CA). IL-1β, osteopontin (OPN), and trans-
forming growth factor (TGF)-β were measured in BAL
by Quantikine ELISA (R&D Systems, Minneapolis, MN).
All assays were conducted as specified by the manufac-
turer’s instructions.
Histology
Lungs were uniformly fixed at 30 cm H2O pressure in
10% formalin for histological assessment. After a mini-
mum of 24 h formalin fixation, lungs were paraffin
embedded, and 4-mm thick slices were cut. The result-
ing slides were stained with hematoxylin and eosin
(H&E) to measure pathological changes and Masson
Trichrome stain to assess collagen deposition. Addition-
ally, immunohistochemistry for the fibroblast marker
vimentin (Rabbit vimentin antibody, Catalogue #5741,
Clone D21H3, 1:100 dilutions; Cell Signaling Technologies,
Danvers, MA) was also performed on formalin-fixed,
paraffin embedded lung tissue sections.
For the quantification of fibrotic lesions, the entire
longitudinal cross-section of the lungs was captured in a
series of images from H&E stained lung sections. From
these images the total cross-sectional area was traced
and measured using ImageJ software (National Institute
of Health, Bethesda, MD). The disease area was defined
by thickened alveolar septa, which corresponded with
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areas of collagen deposition as determined by the Mas-
son Trichrome staining. The disease area was traced
with ImageJ software and expressed as a percentage of
the total cross-sectional area. These measurements were
performed by two independent researchers.
Hyperspectral microscopy
Mitsui-7 fibers were visualized by hyperspectral imaging
as previously described [32]. Hyperspectral images were
taken of H&E stained histology samples using a Cyto-
Viva nanoscale hyperspectral microscope (Cytoviva, Inc.,
Auburn, AL, USA). This imaging system integrates a
visible and near-infrared (VNIR) spectrophotometer
(400–1000 nm), a Dage Excel Color Cooled-M camera,
and an Olympus BX 43 optical microscope. Image acqui-
sition was taken at 100× magnification and analysis was
carried out with Environment for Visualization (ENVI
4.8, Cytoviva, Inc. Auburn, AL, USA) software. Prior to
analysis of samples, a reference spectral library was cre-
ated for Mitsui-7. Spectra from Mitsui-7-exposed sam-
ples were compared to this reference library by Spectral
Angle Mapping, a spectral classification algorithm in
ENVI that used an n-D angle to match pixels from the
treated samples to reference spectra. Spectral similarity
is established between two spectra by calculating the
angle between them and converting them to vectors in a
space with dimensionality equal to the number of bands.
Pixels further away than the maximum angle (radians)
threshold for spectral classification of 0.1 were not
classified.
Collagen and total protein quantification in BAL
Soluble collagen was quantified in BAL fluid by Sircol
assay (Biocolor Life Science Assays, Carrickfergus, UK).
Total protein as an indication of proteinosis was measured
in BAL by Bradford Assay (Bio Rad, Hercules, UK).
RNA isolation and purification
A small random section of the snap frozen right lung
was homogenized immediately in TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) using the Retsch Mixer
MM 400. The RNA was isolated using chloroform and
precipitated using isopropyl alcohol. The RNA was sub-
sequently purified using RNeasy Mini Plus kits (Qiagen,
Mississauga, ON, Canada). Integrity of the RNA samples
was analyzed using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Mississauga, ON, Canada). All samples
had an RNA integrity number above 5.5 and were all
used for microarray analysis.
Microarray hybridization and statistical analysis of
microarray data
For each individual lung tissue sample (n = 5/treatment
group) and Universal Mouse Reference RNA (UMRR,
Stratagene, Mississauga, ON, Canada), 200 ng of total
RNA was used to synthesize cDNA and cyanine-labeled
cRNA (the experimental samples were labeled with
cyanine-5 and cyanine-3 was used to label the reference
RNA) using the Agilent Linear Amplification Kit
(Agilent Technologies, Mississauga, ON, Canada). Labeled
cRNA was transcribed using T7 RNA polymerase and
subsequently purified with RNeasy Mini Kits (Qiagen). An
equimolar amount of reference cRNA was mixed with
each experimental cRNA sample and was hybridized to
Agilent Sureprint G3 Mouse GE 8x60K microarrays
(Agilent) for 17 h at 65 °C in an Agilent SureHyb
hybridization chamber. Immediately following the incuba-
tion period, the arrays were washed and scanned on an
Agilent G2505B Scanner following the manufacturer’s rec-
ommended protocols. Feature Extraction 10.7.3.1 software
(Agilent) was used to extract the gene expression data
from the scanned images.
Normalization and analysis of the data were conducted
in the R environment. The background fluorescence was
measured using the negative control 3xSLv1 probes.
Probes were flagged as absent (within the background
signal) if the median signal intensities were less than the
trimmed mean (trim = 5%) plus three trimmed standard
deviations. Conversely, probes were considered present
if at least four out of the five samples within a condition
had signal intensities greater than three trimmed
standard deviations above the trimmed mean of the
3xSLv1 probes. Data were normalized using Locally
WEighted Scatterplot Smoothing (LOWESS) [33, 34],
and outliers were identified using ratio intensity plots
and heat maps of the raw and normalized data. Differen-
tially expressed genes (DEGs)—increasing or decreasing
relative to the lung tissue samples from age matched
control mice—were determined using the MicroArray
ANalysis Of VAriance (MAANOVA) library in R. This
statistical model included the fixed effects slide and
treatment condition, and was applied to the log2 of
the relative intensities. The Fs statistic was used to
test for treatment effects [35]. The p values for all
statistical tests were estimated by the permutation
method of that consisted of residual shuffling followed by
the false discovery rate (FDR) approach to adjust for
multiple comparisons [36]. A gene was considered
significant if the FDR adjusted p value of the fold change
in the experimental group relative to the control was less
than 0.05.
Pathway analysis of DEGs
Subsequent to normalization of the gene expression
data, a short-list of DEGs was generated using the
criteria of an absolute fold change ≥1.5 and an FDR p-
value <0.05. Bar graphs summarizing the up and down-
regulated genes were generated with Prism 5 software
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(GraphPad Software, Inc., La Jolla, CA, USA). Lists of
overlapping DEGs between experimental groups were
generated with Venny [37] and proportional Venn
diagrams were visualized with Venn Diagram Plotter
(Pacific Northwest National Laboratory, Richland, WA,
USA) (http://omics.pnl.gov/software/venn-diagram-plot-
ter). DEGs associated with fibrosis were identified using
the curated list in the Ingenuity Pathway Analysis
knowledgebase (IPA, Ingenuity Systems, Redwood City,
CA, USA).
Real-time PCR (qPCR) validation of microarray data
Mouse fibrosis PCR arrays (PAMM-120Z, SABioscinces,
Frederick, MD, USA) consisting of 86 genes were used
to validate the microarray results. Approximately 800 ng
of total RNA (n = 3 per group) from each of the experi-
mental and control groups of STAT6 WT and KO mice
was reverse transcribed using a RT2 first strand cDNA
synthesis kit (SABiosciences, Frederick, MD, USA).
qPCRs were conducted using RT2 SYBR Green qPCR
Master Mix in a CFX96 Real-Time System (BioRad
Laboratories, Mississauga, ON, Canada) according to the
manufacturer’s instructions. Threshold cycle (Ct) values
were normalized using Gusb as an internal control gene,
and relative expression changes were each gene were de-
termined using online PCR array data analysis software
(SABiosciences, Frederick, MD, USA).
Statistical analysis
Data are expressed as mean ± SEM. Statistical analysis
was carried out using Prism Graphpad software. Student
t-tests or two way ANOVAs were performed to assess
the difference between MWCNT-treated and control
groups, the statistical interaction of gene deficiency was
then determined to assess the statistical significance
relative to wild type. Differences with p < 0.05 were con-
sidered statistically significant.
Results
Neutrophilic inflammation in lungs induced by exposure
to Mitsui-7 is mediated by IL-1 signaling
Mitsui-7 has been shown to elicit a robust inflammatory
response characterized by increased neutrophil influx
and increased expression of inflammatory cytokines and
chemokines acutely (within 24 h) after the exposure in
experimental rodents [30, 38]. IL-1 mediated signaling
has been shown to play a role in the acute inflammation
induced by nanomaterials [39]. Acute inflammation in-
volving chemokines and cytokine secretion has recently
been identified as one of the key events in the
MWCNT-induced AOP leading to lung fibrosis (Fig. 2a)
[13]. To investigate the role of IL-1 in the acute inflam-
matory response elicited by MWCNTs, we first
measured the two isoforms of IL-1, IL-1α and IL-1β, in
the BAL obtained from WT and IL1-R1 KO mice intra-
tracheally instilled with Mitsui-7 by ELISA. Mitsui-7 in-
stillation significantly elevated the concentrations of IL-
1α and IL-1β in the lungs of WT mice 24 h post-
exposure. Both IL-1α and IL-1β levels reached detection
limits at 28 days post-exposure (Fig. 2b) and the results
were not significant.
Next, we conducted differential cell counts in BAL of
WT and IL1-R1 KO mice 24 h and 28 days post-
exposure to Mitsui-7 to quantify the inflammatory
response. The results revealed significant differences be-
tween WT and IL-1R1 KO mice as determined by cellu-
lar infiltration into the lungs and the production of
inflammatory cytokines. Significantly fewer cells were
observed in the BAL of IL-1R1 KO mice compared to
WT mice, mainly attributed to the complete abrogation
of neutrophil influx in BAL fluid (Fig. 2c). However, this
reduced cell number was not observed 28 days post ex-
posure. Indeed, significantly more neutrophils were ob-
served in IL-1R1 KO mice exposed to MWCNTs at this
later time point. In alignment with lack of neutrophil
influx, the levels of the IL-1 regulated inflammatory cy-
tokines CXCL1, IL-6, and IL-12 remained at the basal
levels following exposure to Mitsui-7 at 24 h (Fig. 2d)
post-exposure. In comparison, the number of neutro-
phils and levels of inflammatory cytokines were signifi-
cantly higher in Mitsui-7 treated WT mice compared to
the matched vehicle only treated controls. The expres-
sion of CXCL1 was persistently attenuated at the 28 day
timepoint in KO mice, but there was no suppression of
IL-12 at 28 days (it was enhanced) post-exposure. This
suggests that the suppression of some inflammatory me-
diators is transient and further confirms that IL-1
deficiency primarily affects the acute inflammatory re-
sponse. The reduced expression of CXCL1 in the KO
model is a particularly important observation as this is a
key chemokine in the recruitment of neutrophils to the
lung [40, 41]. These data indicate that IL1-R1 signaling
is involved in Mitsui-7 induced inflammation and its de-
ficiency disrupts the signaling by key inflammatory me-
diators resulting in an abrogated neutrophilic response;
however, this lack of IL-1 signaling is compensated for
by another mechanism at the later timepoint.
To understand if lack of neutrophil influx observed in
IL-1R1 KO mice modifies clearance of these fibers from
lungs, the dispersion of MWCNTs in the lungs of WT
and IL-1R1 KO mice was assessed using the Cytoviva
microscope, which combines darkfield enhanced im-
aging and hyperspectral profiling of the light scattered
to identify MWCNTs. In H&E-stained lung sections of
both WT and KO mice exposed to MWCNTs after 24 h,
this qualitative analysis showed that the majority of
MWCNTs appeared to be interacting with the epithelial
cells that comprise the alveolar septa (Fig. 2e). To a
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lesser extent, MWCNTs could be viewed within
phagocytic cells in the alveolar lumen, and the
morphology of these cells identified them as macro-
phages. There was no difference in localization of
MWCNTs in lung tissue of WT or KO mice; how-
ever, hyperspectral imaging suggested more MWCNT
signal in the lungs of IL-1R1 KO mice compared to
WT lungs at 24 h, but this could not be quantified.
A large fraction of uniformly distributed MWCNTs
was observed in lung sections of both WT and KO
mice 28 days post-exposure. In the areas where
MWCNTs were detected, the alveolar septa were
thick (Fig. 2e) and MWCNTs seemed to be located in
the midst of these thickened areas of epithelial struc-
ture. No differences between WT and KO samples
were apparent.
A
C
D
E
B
Fig. 2 Acute inflammation in response to pulmonary MWCNT instillation is IL-1 dependent. C57BL/6 and IL-1R1 KO mice were intratracheally
administered 162 μg of MWCNTs, and samples were collected 24 h and 28 days later. a Graphical representation of the key event targeted by
IL-1R1 KO. b IL-1α and IL-1β were measured in BAL fluid of WT animals. The horizontal lines indicate limits of detection; IL-1 α – below 2.0 pg
and IL-1 β – 0.04 pg. c The number of total cells, mononuclear cells, and neutrophils was determined from cytospin slides generated from BAL
fluid and cell concentration measurements from BAL. d The inflammatory cytokines CXCL1, IL-6, and IL-12p40 were measured in BAL fluid. e
Distribution of MWCNTs was determined by hyperspectral imaging in H&E stained histology samples. Data represent mean ± SEM. n = 4–5.
Statistical analysis was performed using two-way ANOVA. *p < 0.05, NS = not significant, †statistical interaction with p < 0.05, and NI = no
statistical interaction
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Deficiency in IL-1 signaling does not affect the pathogenesis
of MWCNT-induced fibrotic disease
Next, we sought to assess fibrotic disease development
in IL-1R1 KO mice. First, we measured prototypical
fibrotic mediators in the BAL fluid of MWCNT-exposed
mice. The products of the pro-fibrotic genes CCL2,
osteopontin (OPN), and TGF-β were all increased fol-
lowing MWCNT exposure in WT mice, though TGF-β
was only increased at the 28-day time point (Fig. 3a). In
comparison, the pro-fibrotic chemokine CCL2 was de-
creased in KO mice 24 h after MWCNT exposure, but
increased in KO mice 28 days post-exposure. The upreg-
ulation of OPN was dampened in KO mice 24 h post
exposure, with no significant difference between WT
and KO mice at the 28-day time point. No difference
was observed in the induction of TGF-β between WT
and KO mice. These data suggest a role for IL-1 signal-
ing in the initial induction of some pro-fibrotic media-
tors; however, the role of IL-1 signaling is ultimately
redundant as these pro-fibrotic mediators can be
induced in the absence of IL-1R1 at a later time point.
We assessed the morphological changes to lung tissue
28 days post-MWCNT administration (Fig. 3b). The
H&E stain (Fig. 3b upper panel) was used to identify
areas of thickened alveolar septa. H&E stained histology
samples were prepared and the entire longitudinal cross
section of both lungs were imaged. The total area of the
lungs and diseased areas, as identified by thickened al-
veolar septa, were determined (procedure outlined in
Additional file 1: Figure S1). MWCNTs led to a signifi-
cant increase in quantifiable disease area compared to
vehicle treated matched control lungs, with no difference
observed between WT and KO mice (Fig. 3c).
Masson trichrome stain (Fig. 3b middle panel) was
used to assess whether the exposures led to increased
deposition of collagen, which is indicative of fibrosis in
the metaplastic lesions. Increased collagen deposition
was interspersed throughout the observed lesions in
both WT and KO mice, consistent with previous obser-
vations in MWCNT-exposed lungs [30]. Collagen
positive stain was quantified in Masson trichrome
stained samples and showed a significant increase in col-
lagen deposition induced by MWCNTs, but with no dif-
ferences between WT and IL-1R1 KO mice (Fig. 3d).
Additionally, soluble collagen was measured in BAL
fluid. Significantly more collagen was measured in the
BAL fluid of MWCNT-exposed WT mice as well as in
MWCNT-exposed IL-1R1 KO mice (Fig. 3e).
Immunohistochemistry analysis for the fibroblast
marker vimentin was undertaken to further characterize
the lesions (Fig. 3b lower panel). The lesions in
MWCNT-instilled lungs displayed increased vimentin
signal indicating increased fibroblast proliferation in
these tissues, which is consistent with pulmonary
fibrosis. No differences were apparent in the structure of
the diseased tissue between WT and IL-1R1 KO mice.
In addition to the fibrotic changes, we assessed protei-
nosis by measuring the total protein content of BAL
fluid. IL-1R1 deficiency resulted in increased accumula-
tion of protein in the lungs over the WT mice, suggest-
ing that IL-1R1 KO negatively affects the ability of the
lungs to deal with MWCNT exposure.
Collectively, these data suggest that although IL-1
signaling deficiency attenuates the acute inflammatory
response elicited by MWCNTs, there is no subsequent
difference in the development of fibrotic lesions in WT
and IL-1R1 KO mice.
IL-1R1 deficiency initially impacts over half of all MWCNT-
induced differentially expressed genes and fibrotic genes
Whole-transcriptome analysis was utilized to more
understand the effects of IL-1R1 deficiency on the pul-
monary response to MWCNT exposure. Total RNA was
isolated from the lung tissue of mice 24 h and 28 days
after exposure to MWCNTs and global gene expression
changes were assessed by microarrays in both WT and
KO mice. This analysis identified 1724 DEGs in WT
mice, with 1038 upregulated genes and 686 downregu-
lated genes 24 h after MWCNT exposure (Fig. 4a).
Fewer DEGs were identified in the IL-1R1 KO mice at
the 24-h time point, with 1025 DEGs observed, 598 of
which were upregulated and 427 DEGs were downregu-
lated. The biological response to MWCNTs seemed less
pronounced 28 days after exposure as 478 DEGs were
observed in WT mice (412 upregulated and 66 downreg-
ulated). Similar results were observed in the KO mice at
28 days with 503 DEG identified (409 upregulated and
94 downregulated).
Venn diagrams were used to assess the similarities and
differences in DEGs between WT and KO mice (Fig. 4b).
KO mice exhibited fewer DEGs at the 24 h post-
exposure time point relative to WT mice. Moreover, a
large subset of genes was only differentially expressed in
KO mice, and over half of the DEGs found in WT mice
were unique to WT at 24 h time-point. At 28 days post
exposure, about a third of the DEGs in WT mice were
not differentially expressed in KO mice, with an almost
equal number of DEGs only expressed in the KO. The
results suggest that initial response to MWCNTs is at-
tenuated by the absence of IL-1 signaling; however, this
attenuation is transient as by 28 days post-exposure
there is a much lesser degree of difference between the
WT and KO mice.
The IPA knowledgebase was used to identify DEGs
from the microarray experiments that are associated
with fibrosis. The results are visualized by a heat map
(Fig. 4c). The heat map is ordered by the greatest differ-
ence in expression between WT and KO mice. Genes
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such as Mt2, Serpinc1, Hpx, and APoa1 were induced by
MWCNT exposure, and attenuated in KO mice; however,
this attenuation was less pronounced or undetectable at
the 28 day time point. Generally, the difference in expres-
sion of genes associated with fibrosis between WT and
KO mice 28 days after exposure was modest, which is
consistent with the inability to detect a difference in the
development of fibrotic disease at the 28 day time point.
STAT6 Signaling contributes to neutrophilic inflammation
in lungs induced by exposure to Mitsui-7
STAT6 mediated signaling plays an integral role in the
development of fibrosis in animal models [24, 25].
STAT6 has also been shown to be part of the Th2
response activated by MWCNT exposure [26], and this
healing response is a key event in the MWCNT-induced
adverse outcome pathway leading to lung fibrosis
A
B C
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Fig. 3 Fibrotic disease is not attenuated 28 days after MWCNT exposure. C57BL/6 and IL-1R1 KO mice were intratracheally administered 162μg of
MWCNTs, and samples were collected 24 h and 28 days later. a The pro-fibrotic genes CCL2, osteopontin (OPN), and total TGF-β levels including
the active form were measured by ELISA. b Representative histology images of the diseased area of lungs 28 days after MWCNT instillation compare WT
and IL-1R1 KO mice. These images were obtained from slides stained with H&E, Masson Trichrome for collagen deposition (blue), and immune-staining for
Vimentin, a surface marker of fibroblasts (brown). The scale bar represents 50 μm. c Entire longitudinal cross sections of the lungs were imaged and the
disease area verses the total lung area were determined to quantify the pathology in H&E stained samples 28 days post exposure. d Representative images
of pathology were taken of the Masson trichrome stained slides and the amount of collagen positive stain was quantified and normalized as a percent of
area imaged. Non-diseased areas from exposed mice were used as controls. e Soluble collagen was measured in the BAL fluid at the 28 day time point,
and f total protein was measured in BAL as well. Data represent mean ± SEM. n = 4–5. Statistical analysis was performed using two-way ANOVA. *p < 0.05,
NS = not significant, †statistical interaction with p < 0.05, and NI = no statistical interaction
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(Fig. 5a) [13]. Following the same experimental protocol
as the IL-1R1 KO experiments, inflammation and lung
pathology 24 h and 28 days post MWCNT exposure in
STAT6 WT and KO mice was investigated. First, the im-
portance of STAT6 in the production of Th2-associated
genes was confirmed by measuring IL-5 in the BAL of
MWCNT-exposed mice. As shown in Fig. 5b, MWCNT
instillation significantly elevated the concentrations of
IL-5 in the lungs of STAT6 WT mice, but this response
was significantly attenuated in STAT6 KO mice. This re-
duction was not observed at the 28 day time point, but
IL-5 was induced at much lower levels in STAT6 WT
and KO mice at this time point.
Next, lung inflammation was assessed by conducting
differential cell counts in the BAL of WT and STAT6
KO mice at 24 h and 28 days post-exposure to Mitsui-7
(Fig. 5c). No difference was observed at either time point
with the total cell count or mononuclear cell counts in
A
B
C
Fig. 4 IL-1 deficiency differentially affects more MWCNT-induced fibrotic genes at 24 h compared to 28 days. RNA was isolated from the lung tissue of
MWCNT-administered mice 24 h and 28 days post-exposure. a The number of DEGs is visualized by a bar chart and the number of significant (at least
a 1.5 fold change and an FDR adjusted p < 0.05) DEGs between WT and IL-1R1 KO mice is indicated for both time points. b Venn analysis was used to
visualize the degree of overlap between increasing and decreasing DEGs at the 24 h and 28 day time points. c A heat map visualizing all of the DEGs
involved in inflammation and fibrosis is shown. The genes are ordered based on the difference in expression between WT and IL-1R1 KO mice
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Fig. 5 (See legend on next page.)
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STAT6 KO mice 24 h post exposure; however, signifi-
cantly less neutrophils were observed in the KO mice.
With respect to inflammatory cytokines, STAT6 KO
mice produced significantly less CXCL1, IL-6, and IL-12,
as measured in BALF by ELISA at 24 h post Mitsui-7
exposure (Fig. 5d). Indeed, there was no significant
increase above control levels at 24 h-post exposure for
any of these cytokine. CXCL1 continued to be signifi-
cantly suppressed at the 28 day time point, while IL-6
and IL-12 responses were similar in both WT and KO
mice at this later time point. These data demonstrate
that STAT6 signaling contributes to the acute inflamma-
tory response to MWCNTs, but to a lesser extent than
IL-1R1 signaling.
To assess the distribution of fibers in the lungs of
STAT6 KO mice, the dispersion of MWCNTs was visual-
ized using the Cytoviva microscope at 24 h and 28 days
post-exposure. This qualitative analysis showed that the
majority of MWCNTs appeared to be interacting with the
epithelial cells that comprise alveolar septa, with some
present in phagocytic cells of the lung lumen (Fig. 5e).
These observations were similar to those made in IL-1R1
KO mice and their corresponding controls. Also, similar
to IL-1R1 KO mice, the lungs of STAT6 KO mice
appeared to contain a higher burden of MWCNTs, but
could not be quantified. This observation would be con-
sistent with inflammation playing an important clearance
role early after MWCNTadministration.
Deficiency in STAT6 signaling reduces MWCNT-induced
fibrotic disease
Similar to the IL-1R1 KO studies, the expression of
prototypical mediators of fibrotic disease were investi-
gated. The products of the pro-fibrotic genes CCL2,
osteopontin (OPN), and TGF-β were measured in the
BAL of MWCNT-exposed mice. In concordance with
our previous findings, all of these genes were elevated
following MWCNT exposure in WT mice, with the ex-
ception of TGF-β at the 24 h time point (Fig. 6a). CCL2
response was diminished relative to wild type (not above
its matched controls) in KO mice 24 h after MWCNT
exposure. However, CCL2 was not only significantly
greater than controls in KO mice 28 days post exposure,
but was also a significantly greater response than ex-
posed WT at this time point. OPN was also dampened
in KO mice relative to WT 24 h post exposure, but no
significant difference was found between WT and KO
mice at the 28-day time point. No difference was
observed in the induction of TGF-β between WT and
KO mice. These data imply that STAT6 signaling plays
an important role in the early expression of these pro-
fibrotic mediators, but that STAT6 signaling is not crit-
ical for the upregulation of these mediators 28 days post
Mistui-7 exposure.
Morphological changes were assessed in lung tissue
28 days after MWCNT administration (Fig. 3b). In order
to quantify the fibrotic area in lungs, the entire longitu-
dinal cross section of both lungs was imaged from each
H&E stained histology samples. Representative images of
the diseased area suggest that MWCNTs caused a
significant increase in quantifiable disease area in WT
mice, and that the thickening of the alveolar septa was
reduced in STAT6 KO mice (Fig. 6c). Collagen positive
stain was quantified in Masson trichrome stained
samples and showed a significant increase in collagen
deposition induced by MWCNTs in WT mice. However,
significantly less collagen positive stain was quantified in
STAT6 KO mice (Fig. 3d) relative to the WT response.
Additionally, soluble collagen was measured in BAL
fluid. Significantly more collagen was found in BAL fluid
from MWCNT-exposed WT as well as STAT6 KO mice
(Fig. 6e) but a larger effect was observed in the KO mice.
Immunohistochemistry for the fibroblast marker found
that the lesions in STAT6 KO mice stained positive for
vimentin similarly to WT mice. The images support the
involvement of STAT6 signaling in the development of
MWCNT-induced lung fibrosis.
Additionally, we assessed proteinosis by measuring the
total protein content of BAL fluid in these experiments
and, similar to IL-1R1 KO mice, STAT6 deficiency lead
to an increased amount of protein accumulating in the
lungs (Fig. 6f ).
STAT6 Deficiency initially impacts half of all MWCNT-induced
differentially expressed genes and leads to sustained
attenuation of expression of specific fibrotic genes
The effects of STAT6 deficiency on the pulmonary re-
sponse to MWCNT exposure was assessed by whole
transcriptome analysis 24 h and 28 days after exposure
to MWCNTs. This analysis revealed 1633 DEGs in WT
(See figure on previous page.)
Fig. 5 Acute inflammation in response to pulmonary MWCNT instillation is partially STAT6 dependent. C57BL/6 and STAT6 KO mice were
intratracheally administered 162 μg of MWCNTs, and samples were collected 24 h and 28 days later. a Graphical representation of the key event
targeted by STAT6 KO. b IL-1α and IL-1β were measured in BAL fluid of WT animals. c The number of total cells, mononuclear cells, and neutrophils
was determined from cytospin slides generated from BAL fluid and cell concentration measurements from BAL. d The inflammatory cytokines CXCL1,
IL-6, and IL-12p40 were measured in BAL fluid. e Distribution of MWCNTs was determined by hyperspectral imaging in H&E stained histology samples.
Data represent mean ± SEM. n = 4–5. Statistical analysis was performed using two-way ANOVA. *p < 0.05, NS = not significant, †statistical interaction
with p < 0.05, and NI = no statistical interaction
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mice, with 954 upregulated genes and 679 downregu-
lated genes 24 h after MWCNT exposure (Fig. 7a).
Fewer DEGs were found in the KO mice at the 24-h
time point, with 1112 DEGs observed, 700 of which
were upregulated and 412 of which were downregulated.
The biological response to MWCNTs was less pro-
nounced 28 days post exposure, with 798 DEGs in WT
mice (508 upregulated and 290 downregulated). Simi-
larly, STAT6 KO mice at 28 days had reduced response
relative to 24hs, with 503 DEGs (335 upregulated and
156 downregulated).
To assess the similarities and differences in the gene
expression profiles of WT and KO mice, Venn diagrams
were produced (Fig. 7b). This analysis visualized the
A
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Fig. 6 Fibrotic disease but not traditional fibrotic markers are attenuated 28 days after MWCNT exposure. C57BL/6 and STAT6 KO mice were
intratracheally administered 162 μg of MWCNTs, and samples were collected 24 h and 28 days later. a The pro-fibrotic genes CCL2, osteopontin
(OPN), and total TGF-β levels including the active form were measured by ELISA. b Representative histology images of the diseased area of lungs
28 days after MWCNT instillation compare WT and STAT6 KO mice. These images were obtained from slides stained with H&E, Masson Trichrome
for collagen deposition (blue), and immune-staining for Vimentin, a surface marker of fibroblasts (brown). The scale bar represents 50 μm. c Entire
longitudinal cross sections of the lungs were imaged and the disease area versus the total lung area was determined to quantify the pathology
in H&E stained samples 28 days post exposure. d Representative images of pathology were taken of the Masson trichrome stained slides, and the
amount of collagen positive stain was quantified and normalized as a percent of area imaged. Non-diseased areas from exposed mice were imaged as
controls. e Soluble collagen was measured in the BAL fluid at the 28 day time point, and f total protein was measured in BAL as well. Data represent
mean ± SEM. n = 4–5. Statistical analysis was performed using two-way ANOVA. *p < 0.05, NS = not significant, †statistical interaction with p < 0.05,
and NI = no statistical interaction
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effect STAT6 deficiency has on the biological response
to MWCNT. About 75% of the DEGs in STAT6 KO
mice were shared with the WT mice at the 24 h time
point. Thus, a relatively small proportion of unique
DEGs were found in STAT6 KO mice. This suggests that
STAT6 deficiency suppresses a portion of the response
to MWCNT rather than altering the response to a dif-
ferent set of DEGs. This pattern of gene expression was
found for both the 24 h and 28 day time points, indicat-
ing that the effects of STAT6 deficiency affect both the
acute and chronic response to MWCNTs in a similar
capacity.
We focused our subsequent analysis on genes associ-
ated with the development of fibrosis as above. A heat
map of all the DEGs associated with the fibrosis pathway
showed a subset of DEGs whose expression differs
A
B
C
Fig. 7 STAT6 deficiency suppresses fibrotic genes 24 h and 28 days post MWCNT exposure. RNA was isolated from the lung tissue of MWCNT-
administered mice 24 h and 28 days post-exposure. a The number of differentially expressed genes (DEGs) is visualized by a bar chart and the
number of significant (at least a 1.5 fold change and an FDR adjusted p < 0.05) DEGs between WT and STAT6 KO mice is indicated for both time
points. b Venn analysis was used to visualize the degree of overlap between increasing and decreasing DEGs at the 24 h and 28 day time points.
c A heat map visualizing all of the DEGs involved in inflammation and fibrosis is shown. The genes are ordered based on the difference in expression
between WT and STAT6 KO mice
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between wild type and KO mice, and a subset of genes
that were largely unaffected by STAT6 deficiency. The
heat map is ordered by the greatest difference in expres-
sion between WT and KO mice. These data indicate that
the fibrotic genes Arg1, Arg2, Ccl24, and Adra2A were
significantly upregulated in WT mice, but not in KO
mice, at both times points post MWCNT exposure. Of
note, Arg1, Arg2, Ccl24, and Retnlb were significantly
altered in WT mice at 28 days but not in STAT6 KO
mice. These genes are positively associated with alterna-
tively activated M2 macrophages [42, 43]. M2 macro-
phages are crucial contributors to the development of
fibrosis [44], and these data implicate M2 macrophage-
associated genes with the development of MWCNT-
induced fibrosis (Fig. 7c).
To further search for an explanation for the differ-
ences in fibrosis development between IL-1R1 and
STAT6 KO mice, the expression of 86 individual genes
that are suggested to be associated with fibrosis was
assessed in lung tissues derived from both the IL1-R1
and STAT6 experiments by RT-PCR (Fig. 8). This re-
vealed 5 specific genes whose expression was signifi-
cantly different in the STAT6 KO model 28 days post
MWCNT exposure compared to the MWCNT-treated
STAT6 WT mice: Ccl11, Col1a2, Mmp9, Nfkb1, and
Smad2. Of these, only Ccl11 was upregulated by
MWCNT exposure, and this expression was significantly
attenuated in STAT6 KO mice. Ccl11 expression was
not significantly altered in IL-1R1 KO mice. These data
suggest that in addition to M2 macrophage-associated
genes mentioned above, Ccl11 is another gene that dif-
ferentiates the response between STAT6 KO and IL-1R1
KO mice.
Discussion
An effective human health risk assessment strategy to
identify the potential pathological effects of NMs, in-
cluding MWCNTs, will require a detailed understanding
of the biological mechanisms involved. It has been well
documented that exposure of experimental rodents to
MWCNTs results in chronic inflammation and lung
fibrosis [26, 28, 30]. It has also been suggested that lung
inflammation induced both acutely and at the adaptive
phases following exposure to MWCNTs plays an
important role in the fibrotic disease process [13]. How-
ever, no studies have been conducted to systematically
investigate the role of inflammation in MWCNT-
induced fibrosis.
In this study, knock out models were used to specific-
ally inhibit the acute and chronic phases of inflamma-
tion, as described in the AOP, to define the essentiality
of two inflammatory pathways to the overall pathogen-
esis of lung fibrosis induced by MWCNTs [13]. Specific-
ally, the IL-1 signaling pathway was targeted to inhibit
the acute inflammatory event, and STAT6 mediated
signaling was targeted to inhibit the healing response as-
sociated with the chronic inflammatory phase. Mitsui-7
is known to induce fibrotic lesions in rodent models,
and the dose and post-exposure timepoints in this
experiment were chosen to: (1) keep the experimental
parameters consistent with previous studies [30]; (2)
allow for more meaningful comparative analyses in the
future; (3) be relevant to occupational exposure levels.
Although the dose used in this study is high, it enabled
greater sensitivity in measuring the potential differences
in the response to MWCNTs between WT and KO mice.
The study results showed that both IL-1R1 and STAT6
mediated signaling are involved in acute inflammation
induced by MWCNT exposure. The results also showed
that while IL1-R1 signaling is redundant for lung fibro-
sis, STAT6 mediated Th2 response is essential in the
process of fibrosis induced by biopersistent MWCNTs.
The role of IL-1 signaling in fiber-induced inflamma-
tion and fibrosis has not been investigated. Although it
has been established that disrupting inflammatory medi-
ators attenuates fibrosis with other causative agents [11],
these data have been generated in experimental models
where the substances used to induce fibrosis exhibit dif-
ferent physical and chemical properties from high aspect
Fig. 8 PCR array identified the suppression of different fibrotic genes
in IL-1R1 KO and STAT6 KO mice. A PCR array of fibrosis-associated genes
was performed on RNA isolated from C57BL/6, IL-1R1 KO, and STAT6 KO
mice 28 days after MWCNT challenge. Five genes were identified as
significantly different between KO and WT mice exposed to MWCNTs in
either STAT6 or IL-1R1 KO mice. Data represent mean ± SEM. n = 3.
Statistical analysis was performed using t-tests. *p < 0.05
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ratio materials such as MWCNTs. To our knowledge, no
published study has directly targeted IL-1R1 in a model
of asbestos exposure. It has been shown that mice
deficient in the inflammasome component NALP3—a
necessary component for IL-1β processing and relea-
se—mount an attenuated inflammatory response when
exposed to asbestos [45]; however, its implication to
asbestos-induced lung pathology has not been investi-
gated. Rydman et al. targeted IL-1 signaling in a model
of MWCNT exposure [21], and showed that IL-1R1
deficiency attenuates acute inflammation, which is
consistent with the results of the present study. Interest-
ingly, Rydmen et al. did not observe reversal of the at-
tenuated inflammatory process at 28 days post-exposure,
which is in contrast to the results observed here. This
discrepancy could be due to the lower doses used by
Rydmen et al., which may have led to effective clearance
of MWCNTs by other mechanisms. However, the study
did not assess the impacts of the attenuated inflamma-
tion on fibrotic process. In Gristman et al., the role of
IL-1 signaling in MWCNT-induced fibrotic pathology
was evaluated [46]. This study showed that acute neutro-
philic response following exposure to MWCNTs was
dampened at 24 h post-exposure but the fibrotic path-
ology was exacerbated in MWCNT-treated IL-1R1 defi-
cient mice at 28 days post-exposure compared to the
wild type mice, suggesting that lack of neutrophilic
clearance of MWCNTs acutely after the exposure may
have exacerbated the disease response in these mice
[46]. In support of this hypothesis, darkfield microscopy
revealed higher amount of MWCNTs in lungs of IL-1R1
deficient mice at 24 h post-exposure compared to the
wild type mice in the present study. Moreover,
statistically significant increases in TGF-β protein levels,
a potent pro-fibrotic cytokine and a strong immunosup-
pressive molecule, at the acute time point (24 h) after
exposure to MWCNTs. In addition, moderate (non-sig-
nificant) increases in the total collagen deposition was
also observed in MWCNT-treated IL-1R1 deficient mice.
We further expand on the findings of these studies
mentioned above, and show that MWCNT-induced lung
fibrosis proceeds in the absence of acute phase IL-1 sig-
naling mediated inflammation and demonstrate that it
may be partially driven by STAT-6 signalling. Few other
studies have shown disengagement between innate im-
mune responses and ultimate lung fibrosis in a mouse
model after exposure to silica [47]. This study character-
ized the role of innate immune responses in lung fibrosis
using 11 individual knock out mouse models lacking dif-
ferent members of IL-1 family including, ASC, NALP3,
IL-1R, IL-18R, ILK-33R, IL-1a and IL-1b, as well as
other innate immune response mediators such as
MyD88, TLR2/4, TLR3, TRIF, IL-23p19, and TCRδ. The
study concluded that fibrosis induced by silica can occur
in the absence of innate inflammatory responses [47]. In
another study, inhibition of innate immune responses
via treatment with dexamethasone, COX inhibitor pirox-
icam or the phosphodiesterase 5 inhibitor sildenafali was
shown to have no impact on total collagen content in
mouse lungs exposed to silica [48]. Although silica used
in Lo Re et al. differs in its properties compared to the
MWCNT type used in the present study, the results are
supportive of the findings.
Our results are unique from the well-established bleo-
mycin model of fibrosis, in which the end results of
tissue injury, chronic inflammation, and pulmonary fi-
brosis induced by bleomycin were attenuated in IL-1R1
deficient mice [20, 49]. While the gene expression pat-
terns following exposure to bleomycin and MWCNTs
show some similarities, the apparent differences in the
end toxicity outcome in IL-1R1 KO mice can be attrib-
uted to the nature of the fibrosis-inducing substance.
Bleomycin is a small molecule drug with a half-life of
less than an hour in the lungs of C57BL/6 mice [50],
while the hyperspectral imaging of mouse lungs exposed
to Mitsui-7 in the present study indicates that the fibers
are not readily cleared from the lungs and persist for at
least 28 days post exposure. Although the acute response
to both bleomycin and MWCNTs may be IL-1
dependent, the biopersistant nature of MWCNTs result-
ing in chronic interaction with the pulmonary environ-
ment may oblige other inflammatory mechanisms
compensating for the IL-1R1 deficiency, explaining the
observed reengaged neutrophil influx at 28 days post-
exposure. It is also possible that the late inflammatory
and fibrotic responses are not dependent on the IL-1
axis, including in WT mice. Interestingly, in STAT6 KO
mice, expression of IL-1α was suppressed at 24 h post-
exposure (data not shown). These results imply that it is
a possibility that suppression or abrogation of lung fibro-
sis may require parallel inactivation of both acute and
adaptive immune responses. Further studies involving
both dose and time series are needed to fully elucidate
the role of IL-1 axis in MWCNT-induced lung path-
ology. Considering the critical role of the inflammatory
response in the maintenance of cellular homeostasis, the
results presented suggest that it may not be possible to
achieve complete and sustained abrogation of inflam-
mation by targeting a single gene or pathway in the
presence of a persistent active toxicant. It can also be
suggested that abrogation of innate immune responses
acutely after the exposure, may trigger activation of
immunosuppressive Foxp3+ regulatory T (T reg) cells
that exhibit profibrotic acitvities and secrete high
levels of TGF-b. Persistence and accumulation of im-
munosuppressive T reg cells has been shown to con-
tribute to silica induced lung fibrosis in mice by
TGF-b autocrine signaling pathway mediated secretion
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of platelet-derived growth factor resulting in stimula-
tion of fibroblasts [51].
Collectively, our findings suggest that the early bio-
logical response is extensively altered by IL-1 deficiency,
and although IL-1α and IL-1β may not be crucial
components of MWCNT-induced fibrosis, this observa-
tion hints at an important role for these genes in sensing
the damage elicited by MWCNTs. The sensing of
damage is a key initiating step in the propagation of an
inflammatory response, and this is accomplished by rec-
ognizing damage associated molecular patterns
(DAMPs) [52]. IL-1 family members have been proposed
as canonical DAMPs that initiate inflammatory re-
sponses after tissue damage [53]. This hypothesis is sup-
ported by experiments that target IL-1α to ameliorate
the inflammation induced by necrotic cells [54].
MWCNTs are cytotoxic to certain cell lines [55], and it
is likely that the specific properties of pathogenic
MWCNTs allow for interactions with pulmonary cells
that results in necrosis. The DAMPs that are released by
these necrotic events then initiate the inflammatory re-
sponse associated with MWCNT inhalation. IL-1α and
IL-1β could then be considered important DAMPs or
early mediators in initiating MWCNT-induced inflam-
mation. Adopting this understanding of the role of IL-1
signaling in the response to MWCNT inhalation ex-
plains why IL-1R1 is redundant at chronic time points in
our model. Many molecules can act as DAMPs, and it is
believed that DAMP inflammatory signaling is funda-
mental for survival, which may necessitate redundant
signaling pathways consistent with our observations
[56]. Considering IL-1α as a DAMP and and IL-1β as
one of the sensitive early responder implies that while
these genes may not be crucial mediators of MWCNT-
induced fibrosis, they may be considered important
biomarkers of the MWCNT-induced lung damage that ul-
timately leads to fibrosis. As such, IL-1α and IL-1β may
still be useful in future MWCNT screening strategies.
One of the other long term responses to MWCNTs in
IL-1R1 KO mice was the development of pulmonary al-
veolar proteinosis. While its relevance to the end path-
ology of MWCNT-driven lung fibrosis in mice is not
known at present, similar findings of increased BALF
protein was also reported by Huaux et al. in IL-1R1, IL-
1α or Myd88 deficient mice but not in IL-1β or ASC
deficient mice exposed to silica particles [57]. The
authors suggested that proteinosis was associated with
limited clearance of particles and that in the absence of
IL-1R1 or IL-1α, particle clearance is greatly impacted.
In the present study, suppression of acute inflammatory
responses and BALF proteinosis was also observed in
STAT6 KO mice, which showed suppressed IL-1α ex-
pression at 24 h post-exposure (unpublished data) and
acute inflammatory responses, suggesting that indeed,
suppression of IL-1α axis or acute innate immune
responses in general, resulting in impaired clearance of
particles may be causal to proteinosis.
The presence of toxic fibers, their physical interaction
with surrounding tissue, and resulting tissue injury sub-
sequently induce a Th2 response leading to regulation of
inflammation, which seems to play a detrimental role in
MWCNT-induced lung fibrosis [58, 59]. Targeting of
Th2-mediated signaling by STAT6 KO clearly showed
the criticality of this signaling in the development of fi-
brosis. The Th2 response is central to allergic disease,
and our findings are consistent with other studies that
have shown a relationship between MWCNT exposure
and allergic disease. Experimental models of allergic air-
way disease are exacerbated by MWCNT exposure [60],
and MWCNTs can be used as an adjuvant to sensitize
mice to an allergen [61]. In a study by Katwa et al. it was
shown that activation of Th2 response involving IL-1
like cytokine IL-33 is critical for acute inflammation and
lung fibrosis induced by carbon based nanomaterials in-
cluding MWCNTs [62]. STAT6 has been shown to be
activated by MWCNT exposure, and our study repre-
sents the first evidence of the significant role it plays in
MWCNT-induced fibrosis [26]. Of note, STAT1 has
been investigated in a model of MWCNT and allergen
exposure [63], and found to play an opposite role to our
findings with STAT6.
Our data suggests the role of STAT6 signaling in our
model may be specifically tied to the role of M2 macro-
phages. The term M2 macrophage typically describes an
alternatively activated macrophage that can fill a
spectrum of roles from immune regulation to wound
healing (reviewed in [64]). Enhancing the activation of
M2 macrophages has been shown to accelerate the heal-
ing process [65], and the ability of M2 macrophages to
facilitate healing implicates excessive and prolonged M2
activation as a mechanism of fibrosis development.
Bleomycin-induced pulmonary fibrosis models indicate a
critical role for M2 macrophages in disease pathogenesis
[66, 67]. However, the role of M2 macrophages in
MWCNT-induced pathology has been largely unstudied,
although M2 macrophage markers have been observed
after MWCNT stimulation in a culture system [68]. Our
data expand on this in vitro observation, and suggest
that the ability of MWCNTs to lead to sustained activa-
tion and presence of M2 macrophages within lung tissue
is a KE in the development of MWCNT-induced
pathology. Specifically, the M2 macrophage-associated
genes Arg1, Arg2, Ccl24, and Retnlb could be incorpo-
rated into future screening strategies as disease
biomarkers. However, it is important to note that the
present study did not specifically assess M2 macro-
phages and thus, further studies are needed to support
these conclusions.
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The redundancy of IL-1 signaling in the development
of fibrosis highlights the strength of applying an AOP
framework to guide mechanistic studies. Inflammation
occurs early in the response to inhaled MWCNTs and is
such a fundamental response to so many insults that
multiple pathways are available to eventually compensate
for the lack of an initial inflammatory response. The
AOP framework readily enables the identification of
downstream events for research that may be more spe-
cific to the AO, and thus directs more meaningful mech-
anistic studies. In our experiment this led us to target
wound healing as a later KE. Our work here led to an
unexpected finding on the effect of STAT6 deficiency on
the acute inflammatory response. STAT6 is traditionally
known as a signaling pathway that is initiated later in
the response to inflammatory stimuli and is associated
with the eventual suppression of inflammation. However,
STAT6 KO mice elicit a blunted neutrophilic response
after infection with pneumocystis [69]. Our experiment
provides additional insight into the role of STAT6 in the
acute inflammatory response, as well as the subsequent
Th2 response. Ultimately, placing our mechanistic data
within the context of an AOP helps place our negative
results related to IL-1R1 deficiency into perspective and
strengthens the observed role of STAT6 in MWCNT-
induced pathology. Overall, the AOP framework facili-
tates the identification of data gaps, uncertainties and in-
consistencies in hypothetical pathways. The weight of
evidence approach applied in AOP development is also a
very useful tool enabling rapid identification of necessary
hypothesis-directed research.
In the present study, a potential link between lung in-
flammation and lung fibrosis was explored with the
hypothesis that inflammation is essential to the process
of fibrosis and that it precedes and accompanies fibrosis.
The results presented show that some components of
the inflammatory process may be involved in the fibrotic
disease development but that the hypotheses cannot be
generalized to all types of inflammatory processes. As
reviewed in Luzina et al. the interaction between inflam-
mation and fibrosis could be 1) direct – the underlying
mechanisms that drive MWCNT-induced inflammation
also drive the fibrosis pathology, 2) indirect – the mech-
anisms driving MWCNT-induced inflammation and
lung fibrosis are initiated independently but some level
of interaction between the two processes occur and may
contribute to the disease progression, and 3) independ-
ent or no interaction – inflammation and fibrosis occur
independent of each other [70]. From the present study,
it can be concluded that the relationship is both direct
and indirect, depending on the type of inflammatory
processes (specific pathways or molecules) and inflam-
matory phases (innate versus adaptive or resolving
phase) considered. Moreover, for nanomaterials, this
interaction or the extent of this interaction could be
dictated by their properties and exposure duration.
Thus, despite the observation that IL-1R1 deficiency did
not alter the final fibrotic outcome following exposure
to MWCNTs, its involvement in the disease process
cannot be entirely ruled out. Moreover, the present study
only considered one acute and one sub-chronic post-
exposure time point. A study including a range of post-
exposure time points may be necessary to fully appreciate
the involvement of the acute inflammatory phase in the
development of MWCNT-induced lung fibrosis.
While the present study has specifically focused on the
potential link between MWCNT-induced lung inflam-
mation and lung fibrosis, other studies have proposed
that fibroblasts proliferation and collagen synthesis to be
the critical events that drive the CNT-induced lung fi-
brosis. Vietti et al. have proposed that different signaling
pathways and biological processes including reactive
oxygen species synthesis, inflammatory pathways and
endocytosis that are activated in different cell types fol-
lowing exposure to CNTs may together orchestrate pro-
liferation and differentiation of fibroblasts, which, in
turn, lead to excessive collagen deposition and fibrosis
[71]. The role of myofibroblasts was discussed in Dong
et al. [72]. The other proposed mechanisms include acti-
vation of inflammasome [73], accumulation of CNTs in
autophagosomes and disruption of autophagy process
[74], activation of TGFb/smad signaling [75], and activa-
tion of epithelial-mesenchymal transition. However, es-
sentiality of these key events or molecules in the disease
process of lung fibrosis induced by carbon nanotubes is
yet to be established.
Conclusions
The findings of this study expand current understanding
of how MWCNTs induce disease. We conclude that sig-
naling through IL-1R1 is a crucial mediator of inflamma-
tory and pro-fibrotic genes 24 h after MWCNT
exposure; however, BAL analysis reveal that chronic in-
flammation is not IL-1R1 dependent, and the formation
of fibrotic lesions 28 days after MWCNT exposure is
not affected by IL-1R1 deficiency. Transcriptome ana-
lysis confirms the transient effects of IL-1R1 deficiency.
The results involving STAT6 KO mice showed that
STAT6 plays a role in the early neutrophilic response to
MWCNT, and significantly suppresses the development
of fibrosis 28 days after MWCNT exposure. Transcrip-
tomic analysis identified fibrotic genes that are sup-
pressed at early and later post-exposure timepoints in
STAT6 KO mice. Our findings define a mechanism for
MWCNT-induced pathology within the context of an
AOP that can be used to better understand the bio-
logical response to MWCNTs and aid in developing an
informed regulatory strategy for these NMs.
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